February 25, 2026
Astellas and Vir Biotechnology Form $1.7B Global Partnership to Advance VIR-5500 for Prostate Cancer
Astellas Pharma and Vir Biotechnology announce a global strategic partnership to advance VIR-5500, a PSMA-targeting dual-masked T-cell engager for prostate cancer, with $335M upfront and up to $1.37B in milestones.
Read More
February 24, 2026
Astellas and Vir Biotechnology Forge Global Collaboration to Advance Prostate Cancer T-Cell Engager VIR-5500
Astellas Pharma and Vir Biotechnology enter strategic collaboration to advance VIR-5500, a dual-masked T-cell engager targeting PSMA in metastatic prostate cancer, with shared development and commercialization plans.
Read More
February 23, 2026
Taltz and Zepbound Data Highlight Dual Benefits in Psoriasis and Obesity Management
New data reveal that Taltz and Zepbound improved outcomes in patients with psoriasis and obesity, highlighting integrated treatment benefits and strategic implications for Eli Lilly.
Read More
February 20, 2026
UAE Launches AI-Driven InSilico Medicine Initiative to Boost Drug Discovery
The UAE’s Emirates Drug Establishment unveils the AI-powered InSilico Medicine project at WHX 2026 to accelerate drug research and reduce R&D costs, enhancing the nation’s biotech landscape.
Read More
February 19, 2026
Merck and Mayo Clinic Partner to Accelerate AI-Driven Drug Discovery
Merck and Mayo Clinic launch a strategic collaboration to integrate AI, clinical, and genomic data for faster, more precise drug discovery in gastroenterology, dermatology, and neurology.
Read More
February 18, 2026
ENTOD launches COLLADERM transdermal collagen gel at DERMACON 2026
ENTOD Pharmaceuticals introduced COLLADERM, a transdermal collagen gel serum for regenerative skincare, at DERMACON 2026, featuring AI-engineered collagen and advanced delivery technology.
Read More
February 17, 2026
Roche’s Gazyva/Gazyvaro Shows Positive Phase III Results in Primary Membranous Nephropathy
Roche reports positive MAJESTY study results, showing Gazyva/Gazyvaro helps patients with primary membranous nephropathy achieve complete remission and maintain kidney function.
Read More
February 16, 2026
CStone Secures US FDA IND Clearance for Trispecific Antibody CS2009 to Enter Phase II Trial
CStone Pharmaceuticals secures US FDA IND clearance for its novel trispecific antibody CS2009 targeting PD-1, VEGF, and CTLA-4, advancing into Phase II clinical trials.
Read More
February 13, 2026
Hexaware and CareInsight Forge Strategic Partnership to Drive AI‑Enabled Healthcare Transformation
Hexaware Technologies and CareInsight announce a strategic partnership to integrate production‑grade AI in healthcare operations, enhancing decision‑making, care delivery, and efficiency across organisations.
Read More
February 12, 2026
Semaglutide Reduces Cardiovascular Risk Independently of Major Weight Loss
SELECT trial results show semaglutide reduces major cardiovascular events in overweight adults independently of weight loss, offering new cardiometabolic benefits.
Read More
February 11, 2026
AI-Enhanced Stethoscope Improves Detection of Valvular Heart Disease
Study shows AI-powered stethoscopes detect more valvular heart disease cases than traditional auscultation, improving early diagnosis and treatment.
Read More
February 10, 2026
Dadachanji Group Launches KAIRISH Innotech to Expand Engineering and Automation Capabilities
Dadachanji Group has launched KAIRISH Innotech, a new company providing customised pharmaceutical machinery, medical devices, robotics, and automation solutions with integrated digital capabilities.
Read More
February 9, 2026
AstraZeneca reports positive Phase III data for baxdrostat in resistant hypertension
AstraZeneca reports Phase III trial results for baxdrostat, demonstrating significant reductions in systolic blood pressure in patients with resistant hypertension and highlighting unmet treatment needs.
Read More
February 6, 2026
Lupin Launches Topiramate Extended-Release Capsules in the United States
Lupin has launched Topiramate Extended-Release Capsules in the US following FDA ANDA approval, expanding its neurology portfolio and entering a USD 164 million market.
Read More
February 5, 2026
Enlil Launches First Evidence-Based Milestone View to Streamline Medical Device Development
Enlil launches Milestone View, connecting medical device development milestones to regulatory and design data to streamline FDA eSTAR preparation and reduce delays.
Read More
February 4, 2026
FDA Accepts Otsuka’s Centanafadine NDA for Priority Review in ADHD
The FDA has accepted and granted priority review to Otsuka’s NDA for centanafadine, a novel triple reuptake inhibitor for ADHD in children, adolescents, and adults, with a PDUFA date of 24 July 2026.
Read More
February 3, 2026
Freudenberg Medical Launches LubriTeq Hydrophilic Coating for Advanced Medical Devices
Freudenberg Medical introduces LubriTeq, a high-performance hydrophilic coating designed to improve lubricity, durability, and patient comfort in minimally invasive medical devices.
Read More
February 2, 2026
FDA Launches PreCheck Pilot to Accelerate U.S. Drug Manufacturing
The FDA launches its PreCheck pilot to accelerate U.S. pharmaceutical manufacturing, prioritizing critical supply facilities and streamlining regulatory reviews to strengthen domestic drug production.
Read More
January 30, 2026
Novo Nordisk Files FDA Application for Next-Generation Obesity Drug CagriSema
Novo Nordisk has filed an NDA with the FDA for its next-generation obesity drug CagriSema, a fixed-dose GLP-1 and amylin combination, with review expected in 2026.
Read More
January 29, 2026
FDA Clears Daratumumab-Hyaluronidase Quadruplet with VRd for Transplant-Ineligible Multiple Myeloma
The FDA approved daratumumab and hyaluronidase-fihj with bortezomib, lenalidomide, and dexamethasone (D-VRd) for adults with newly diagnosed, ASCT-ineligible multiple myeloma, expanding frontline treatment options.
Read More
January 28, 2026
BioMed X and Barbados Government Launch AI-Driven Diabetic Kidney Disease Research Initiative
BioMed X and the Government of Barbados, supported by the EU PharmaNext Programme, launch a collaborative research project using AI and molecular profiling to advance precision medicine for early diabetic kidney disease in populations of African descent.
Read More
January 27, 2026
Bupa Expands Remote Skin Assessment and NHS Trusts Adopt New Digital Tools in Healthcare Innovation Roundup
Bupa launches an expanded remote skin assessment in the UK as NHS trusts adopt digital pathology and EPR systems. Read the latest healthcare innovation developments and their impact on care delivery.
Read More
January 23, 2026
US FDA Accepts Levi-04 IND for Osteoarthritis Treatment
The US FDA has accepted Levicept’s IND application for Levi-04, enabling clinical trials for a novel osteoarthritis therapy.
Read More
January 22, 2026
AI-Enhanced Blood Test for Early Alzheimer’s Detection Now Available in India
India introduces an AI-integrated blood biomarker test for early Alzheimer’s detection, approved by US and Indian regulators, enabling less invasive and earlier diagnosis supported by imaging pathways.
Read More
January 21, 2026
FDA Qualifies First AI Drug Development Tool for Use in MASH Clinical Trials
The FDA has qualified the first AI-based drug development tool, AIM-NASH, to support standardized liver biopsy scoring in MASH clinical trials, enhancing consistency and efficiency.
Read More
January 20, 2026
SAP and Fresenius Partner to Advance AI-Driven Digital Healthcare Across Europe
SAP teams up with Fresenius to deploy AI and cloud technologies, driving digital healthcare transformation and smarter hospital operations across Europe.
Read More
January 19, 2026
China’s Drug and Medical Device Sector Becomes Major Economic Growth Engine
China’s pharmaceutical and medical device industry is projected to surpass US$2.1 trillion in revenue by 2030, driven by ageing demographics, rising healthcare spending, and increased innovation.
Read More
January 16, 2026
SUEDPACK Medica Showcases Advanced Healthcare Packaging Solutions at Pharmapack 2026
SUEDPACK Medica showcases advanced and sustainable pharmaceutical and medical packaging solutions at Pharmapack Europe 2026 in Paris, supporting regulatory and efficiency needs.
Read More
January 15, 2026
Bionpharma Secures US FDA Approval for Etravirine Tablets Developed with SteerLife
Bionpharma receives US FDA approval for Etravirine Tablets developed with SteerLife, strengthening its HIV treatment portfolio in the US market.
Read More
January 14, 2026
Celltrion presents its innovative drug pipeline and U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference, reinforcing long-term growth plans.
Celltrion highlights its drug pipeline and U.S. manufacturing and R&D expansion at the J.P. Morgan Healthcare Conference.
Read More
January 13, 2026
NVIDIA and Eli Lilly Launch AI Co-Innovation Lab to Accelerate Drug Discovery
NVIDIA and Eli Lilly announce a co-innovation lab leveraging AI and accelerated computing to transform drug discovery and speed up pharmaceutical R&D.
Read More
January 12, 2026
PAI Pharma Acquires Nivagen to Strengthen US Injectable Manufacturing
PAI Pharma has acquired Nivagen Pharmaceuticals to enhance injectable drug development, manufacturing capacity, and supply chain resilience in the US.
Read More
January 9, 2026
Storm Therapeutics, AlidaBio Team Up to Advance RNA-Targeting Cancer Therapy Development
STORM Therapeutics and AlidaBio initiate a strategic collaboration to apply advanced RNA modification profiling to support development and biomarker discovery for STC-15, a METTL3 inhibitor in cancer clinical trials.
Read More
January 8, 2026
UK regulator MHRA approves GSK’s Nucala for adults with eosinophilic COPD uncontrolled on triple therapy, expanding biologic options in respiratory care.
UK regulator MHRA approves GSK’s Nucala for adults with eosinophilic COPD uncontrolled on triple therapy, expanding biologic options in respiratory care.
Read More
January 7, 2026
JP Morgan Banker Says Global Pharma Turns to Asia as Partnerships Shape Winners
JP Morgan’s David Lau says global pharma is intensifying its focus on Asia, with partnerships, AI adoption, and cross-border deals shaping future industry winners.
Read More
January 6, 2026
Symbiosis Initiates Commercial Production at New FDA-Inspected Sterile Manufacturing Facility
Symbiosis Pharmaceutical Services has produced its first commercial batch at its new FDA-inspected sterile manufacturing facility in Stirling, supporting a Phase III cancer immunotherapy and expanding its commercial fill/finish capacity.
Read More
January 5, 2026
Insilico Medicine, Servier Forge Up to US$888M AI-Led Oncology R&D Collaboration
Insilico Medicine and Servier enter a multi-year R&D collaboration worth up to US$888 million to accelerate AI-driven oncology drug discovery, combining proprietary technology with global development expertise.
Read More
January 2, 2026
Japan’s D.O.N Unveils VITAL BELT, World’s First Millimeter-Wave Health Sensing Wearable
D.O.N Co. Ltd. announces VITAL BELT — the world’s first belt-type wearable with millimeter-wave sensing for non-invasive tracking of respiration, pulse and body movement, ushering in a new era of daily health monitoring.
Read More
January 1, 2026
India’s Healthcare Backbone Rewired in 2025 Through AI Scribes, Digital Records and Smarter Credit Flows
A summary of how AI scribes, digital health record systems, and smarter financial tools quietly strengthened India’s healthcare operational backbone in 2025, improving efficiency and setting the stage for future integration.
Read More
December 31, 2025
Johnson & Johnson Shares Dip After Closing $3.05bn Halda Therapeutics Acquisition
Johnson & Johnson stock dipped after hours after completing its $3.05 billion acquisition of Halda Therapeutics, adding RIPTAC oncology technology but impacting near-term EPS.
Read More
December 30, 2025
Doctors Urge Caution as Antibiotic Resistance Threatens Global Health
Medical experts in India urge responsible antibiotic use to combat growing antimicrobial resistance, emphasizing prescriptions, proper dosing, and full treatment adherence.
Read More
December 29, 2025
Abu Dhabi Becomes First Worldwide to Deliver ITVISMA Gene Therapy for Spinal Muscular Atrophy
Abu Dhabi marks a global milestone by administering ITVISMA, a one-time gene therapy for SMA, reinforcing its position as a leader in genomics and precision medicine.
Read More
December 26, 2025
Eli Lilly Becomes First Trillion-Dollar Pharma on Weight-Loss Drug Dominance
Eli Lilly surpasses $1 trillion in market value in December 2025, driven by blockbuster demand for its weight-loss and diabetes drugs Mounjaro and Zepbound.
Read More
December 24, 2025
Yusen Logistics Completes Walden Health Acquisition to Expand European Healthcare Platform
Yusen Logistics has completed the acquisition of Walden Health subsidiaries, expanding its European healthcare logistics capabilities across transport, warehousing, and digital services.
Read More
December 23, 2025
AstraZeneca Secures CDSCO Approval for Breast Cancer Drug Datopotamab Deruxtecan
AstraZeneca has received CDSCO approval to import and market Datopotamab Deruxtecan in India, expanding treatment options for metastatic breast cancer patients.
Read More
December 18, 2025
Cambridge, AstraZeneca and Beijing Authorities Form Partnership to Accelerate Healthcare Innovation
The University of Cambridge, AstraZeneca, and Beijing authorities have launched a new partnership to strengthen life sciences collaboration, talent exchange, and healthcare innovation.
Read More
December 17, 2025
Toppan Acquires Asahi Kasei’s Brittle Lidding Technology for Sustainable Blister Packs
Toppan Holdings acquires brittle lidding material patents from Asahi Kasei to develop aluminum-free, eco-friendly push-through blister packs for the pharmaceutical sector.
Read More
December 16, 2025
Scottish Borders Enters UK Medicinal Cannabis Market with £250m Opportunity
Breathe Life Sciences will open a medicinal cannabis manufacturing site in the Scottish Borders, creating jobs and targeting the UK’s fast-growing £250m cannabis medicines market.
Read More
December 15, 2025
Biocon Biologics Secures Global Rights to Commercialize Biosimilar Aflibercept
Biocon Biologics has signed a global settlement with Regeneron and Bayer, enabling worldwide commercialization of its biosimilar Aflibercept YESAFILI starting in 2026.
Read More
December 12, 2025
India and Kenya Advance Talks to Strengthen Pharma, Medtech, and Digital Health Collaboration
India and Kenya are advancing bilateral cooperation in pharmaceuticals, medical devices, and digital health through high-level meetings aimed at improving healthcare access and accelerating digital transformation.
Read More
December 11, 2025
Sanner to Debut Fully Recyclable Tethered Cap at Pharmapack Europe 2026
Sanner will introduce its fully recyclable Tethered Cap at Pharmapack Europe 2026, highlighting sustainability advances and expanded packaging solutions for pharmaceuticals and supplements.
Read More
December 10, 2025
China’s Biopharma Sector Enters ‘Innovation 2.0’ Era, Redefining Global Pharma
China’s biopharmaceutical sector is transitioning to Innovation 2.0, leading in bispecific antibodies, targeted protein degradation, and global licensing deals, reshaping the pharmaceutical landscape.
Read More
December 8, 2025
Takeda Closes Global Oncology Partnership with Innovent Biologics
Takeda finalizes collaboration with Innovent Biologics, securing global rights outside Greater China to late-stage oncology candidates IBI363 and IBI343 with a US$1.2B upfront payment.
Read More
December 5, 2025
D&D Pharmatech Selected to Present at 2026 JPMorgan Healthcare Conference
D&D Pharmatech is set to present interim DD01 Phase 2 results at the 2026 JPMorgan Healthcare Conference, strengthening global partnership discussions.
Read More
December 3, 2025
Avandra Health acquires DatCard and Sorna to Create Unified Medical Imaging Platform
Avandra Health acquires DatCard and Sorna to integrate imaging data sharing with de-identified data aggregation, creating an advanced platform for patient care and medical research.
Read More
December 2, 2025
BSI Introduces World-First Environmental Standard for Pharmaceutical Life Cycle Reporting
BSI releases PAS 2090:2025, a global standard improving environmental life cycle reporting in pharma, supported by NHS England and major industry partners.
Read More
December 1, 2025
InnoCare Begins Global Phase II Trial of TYK2 Inhibitor Soficitinib for Prurigo Nodularis
InnoCare Pharma begins a global Phase II trial of the TYK2 inhibitor Soficitinib for prurigo nodularis, strengthening its autoimmune and dermatology pipeline.
Read More
November 28, 2025
India and Switzerland Explore Deeper Pharma & Biotech Collaboration Amid TEPA Progress
India and Switzerland advance pharma and biotech cooperation, focusing on R&D, investment growth, and progress under the India-EFTA TEPA agreement.
Read More
November 27, 2025
Zydus and RK Pharma Join Forces on New Oncology Supportive Care Injectable
Zydus and RK Pharma collaborate on a sterile injectable oncology supportive care product, with manufacturing by RK Pharma and US commercialization by Zydus.
Read More
November 26, 2025
Thermo Fisher Expands India Presence with Customer Experience and Bioprocess Design Centers in Hyderabad
Thermo Fisher Scientific expands in India with new Customer Experience and Bioprocess Design Centers in Hyderabad’s Genome Valley, promoting research, innovation, and skill development.
Read More
November 25, 2025
Zepto Expands Into Home Diagnostics Through Partnership With Orange Health Labs
Zepto expands its digital health portfolio by adding at-home diagnostics with Orange Health Labs, strengthening its e-pharmacy and healthcare services presence.
Read More
November 24, 2025
NTUH Opens New OPAT Centre to Expand Access to Outpatient IV Antibiotic Care
NTUH opens a new OPAT centre offering outpatient intravenous antibiotic therapy, supported by multidisciplinary teams and telehealth integration in line with national incentives.
Read More
November 21, 2025
Teva Launches “Teva Rise” to Accelerate Global Pharma Innovation Through AI, Industry 4.0 and Digital Health
Teva unveils Teva Rise, a global open innovation platform connecting startups with Teva to drive AI, digital health, Industry 4.0, and biotech solutions across pharma R&D, manufacturing, and supply chain.
Read More
November 20, 2025
Semalytix Raises €5.7M to Advance Agentic AI Platform for Real-World Patient Insights
Semalytix raises €5.7M to enhance its Agentic AI platform, expand global operations, and deliver real-world patient insights to leading pharmaceutical companies.
Read More
November 19, 2025
CSL Announces $1.5 Billion U.S. Investment to Expand Plasma-Derived Therapies Capacity
CSL Limited announces a $1.5B investment to expand U.S. plasma-derived therapies production, strengthen supply chains, and build new biotech facilities supported by strong financial performance.
Read More
November 18, 2025
Sino Biopharm and MediTrust Health Partner to Advance Drug-Insurance Integration Model
Sino Biopharm and MediTrust Health sign a strategic partnership at CIIE 2025 to advance drug-insurance integration, expand access to innovative medicines, and strengthen China’s healthcare ecosystem.
Read More
November 17, 2025
Marksans Pharma’s UK Subsidiary Wins MHRA Approval for Mefenamic Acid Tablets
Marksans Pharma’s UK subsidiary Relonchem receives MHRA approval for Mefenamic Acid tablets, expanding its UK product portfolio and strengthening its international market strategy.
Read More
November 14, 2025
Akums Drugs & Pharma to Invest $24 Million in Zambian Healthcare Subsidiary
Akums Drugs & Pharma will invest $24M in its Zambian subsidiary to build a manufacturing facility, strengthen regional operations, and tap into Africa’s growing $300M pharmaceutical market.
Read More
November 13, 2025
Alembic Pharmaceuticals Secures USFDA Approval for Dexlansoprazole Capsules
Alembic Pharmaceuticals gains USFDA approval for Dexlansoprazole Delayed-Release Capsules (30 mg & 60 mg) for patients 12+, targeting a $285 million US market and expanding its gastrointestinal portfolio.
Read More
November 12, 2025
Cipla, Natco, Hetero, and Annora Secure Major Generic Drug Contracts in China
Cipla, Natco, Hetero, and Annora secure major contracts under China’s VBP program, expanding India’s pharmaceutical presence and boosting access to essential medicines.
Read More
November 11, 2025
MediTrust Health and Sino Biopharm Partner to Advance Drug-Insurance Integration
Sino Biopharm and MediTrust Health sign a strategic cooperation agreement at CIIE 2025 to explore drug-insurance integration, enabling early patient access to affordable innovative medicines.
Read More
November 10, 2025
Pfizer Wins $10 Billion Bidding War for Obesity Drug Developer Metsera
Pfizer wins $10 billion bidding war for Metsera, securing a key position in the obesity drug market after Novo Nordisk withdraws over antitrust and pricing concerns.
Read More
November 7, 2025
Indegene Acquires BioPharm for $106 Million to Strengthen AI-Powered Pharma Marketing
Indegene acquires BioPharm for $106 million, boosting its AI-powered marketing and AdTech solutions for global pharmaceutical companies, strengthening its life sciences commercialization portfolio.
Read More
November 6, 2025
Zydus Receives USFDA Orphan Drug Designation for Desidustat in Beta-Thalassemia
USFDA grants Orphan Drug Designation to Zydus Lifesciences’ Desidustat, a novel HIF-PHI for beta-thalassemia, offering incentives and paving the way for innovative treatment development.
Read More
November 5, 2025
Eli Lilly to Invest $3 Billion in New Manufacturing Facility in the Netherlands
Eli Lilly plans to invest $3 billion in a new oral medicines manufacturing facility in Katwijk, Netherlands, pending local approvals. The move aims to boost global production capacity.
Read More
November 4, 2025
UPS Acquires Andlauer Healthcare Group for $1.6 Billion to Strengthen Global Healthcare Logistics Leadership
UPS has completed its $1.6 billion acquisition of Andlauer Healthcare Group to strengthen its temperature-controlled and specialized healthcare logistics capabilities.
Read More
November 3, 2025
EU and France Invest €10.2 Million to Strengthen Nigeria’s Pharmaceutical Manufacturing Capacity
The EU and France are investing €10.2 million to boost Nigeria’s pharmaceutical manufacturing, promoting health independence and industrial growth.
Read More
October 31, 2025
WHO and Bayer Partner to Strengthen Global Health and Climate-Resilient Healthcare Systems
The WHO Foundation partnered with Bayer AG to support global health efforts, focusing on neglected tropical diseases, self-care, and climate-related reproductive health challenges.
Read More
October 30, 2025
Hanmi Unveils New EP300 Anticancer Degrader and Expands Biotech Pipeline
Hanmi Pharmaceutical announced promising preclinical results for its EP300-selective degrader, a novel anticancer therapy, at an international cancer research conference in Boston.
Read More
October 29, 2025
KPI Green Energy and F Plus Healthcare Technologies Partner to Develop Sustainable Global Data Centers
India’s KPI Green Energy partnered with F Plus Healthcare Technologies to build renewable-powered modular data centers and sustainable high-tech facilities for low-carbon digital growth.
Read More
October 28, 2025
Eli Lilly to Invest $1 Billion in Hyderabad Contract Manufacturing and Oversight Facility
Eli Lilly will invest over $1 billion in a new manufacturing and oversight facility in Hyderabad to boost global medicine supply and create jobs in Telangana.
Read More
October 27, 2025
Novartis Nears $70-Per-Share Deal to Acquire Avidity Biosciences
Novartis AG is reportedly nearing a deal to acquire Avidity Biosciences for over $70 per share, expanding its focus on biotechnology and RNA-based therapeutics.
Read More
October 24, 2025
Strides Pharma to Market WHO-Prequalified Generic Contraceptive DMPA-SC in Africa
Strides Pharma’s subsidiary will market the world’s first WHO-prequalified generic DMPA-SC, Medogen SubQ, across Africa to improve women’s access to affordable reproductive health solutions.
Read More
October 23, 2025
Alkermes Enters Sleep Medicine Market with $2.1 Billion Avadel Acquisition
Alkermes is acquiring Avadel Pharmaceuticals for up to $2.1 billion, gaining access to Lumryz and entering the fast-growing sleep medicine market.
Read More
October 17, 2025
Roquette Opens New Pharmaceutical Innovation Center in Brazil to Boost Latin American Collaboration
Roquette has launched its Health & Pharma Solutions Innovation Center in São Paulo, boosting its focus on advanced drug delivery and innovative health solutions.
Read More
October 16, 2025
Adtalem and Google Cloud Launch AI Credential Program for Healthcare Professionals
Adtalem Global Education and Google Cloud will launch an AI credential program in 2026 to train students and healthcare professionals in using tools like Gemini and Vertex AI for clinical decision-making.
Read More
October 15, 2025
Pfizer CEO Urges Greater U.S.–China Collaboration in Pharma Innovation
Pfizer CEO Albert Bourla urged stronger U.S.-China pharmaceutical collaboration, noting China now contributes nearly 30% of global drug development.
Read More
October 14, 2025
Coveris Partners with SABIC for Closed-Loop Medical Packaging Initiative
Coveris and SABIC have launched the world’s first closed-loop recycling system for medical packaging, turning non-contaminated hospital waste into new sterile pouches.
Read More
October 13, 2025
Natco Pharma to Acquire Majority Stake in South Africa’s Adcock Ingram for Approx. USD 240 Million
India’s Natco Pharma is acquiring a significant stake in South Africa’s Adcock Ingram for around USD 240 million, making the 135-year-old company privately owned by Natco and majority shareholder Bidvest.
Read More
October 10, 2025
Samsung Biologics Launches ExellenS™ Framework
Samsung Biologics has launched ExellenS™, a new framework to enhance and streamline biomanufacturing across its network, leveraging its expertise in plant design, digitalization, and operational excellence.
Read More
October 9, 2025
Alterity Therapeutics Presents Positive Phase 2 Data for ATH434 in Multiple System Atrophy
Alterity Therapeutics reported positive Phase 2 results for ATH434 in Multiple System Atrophy, showcasing its potential as a first-in-class, disease-modifying therapy.
Read More
October 8, 2025
Merck Completes $10 Billion Acquisition of Verona Pharma
Merck (MSD outside the U.S. and Canada) has completed its $10 billion acquisition of Verona Pharma, making it a wholly owned subsidiary and delisting its shares from Nasdaq.
Read More
October 7, 2025
Eli Lilly to Invest Over $1 Billion in India to Boost Manufacturing Capacity
Eli Lilly plans to invest over $1 billion in India to expand local manufacturing and supply, leveraging the country’s skilled pharmaceutical workforce.
Read More
October 6, 2025
Hikma and Celltrion Expand Partnership to Boost Biosimilar Access in MENA
Hikma Pharmaceuticals and South Korea’s Celltrion have partnered to launch six biosimilars in the MENA region, improving access to affordable treatments for cancer, immune, eye, and bone-related diseases.
Read More
October 3, 2025
India to Host Second WHO Global Summit on Traditional Medicine
WHO and the Government of India will co-host the Second Global Summit on Traditional Medicine in New Delhi from 17–19 December 2025, focusing on global collaboration and innovation in traditional medicine.
Read More
October 1, 2025
Klotho Neurosciences Signs LOI to Acquire Turn Biotechnologies Assets
Klotho Neurosciences (Nasdaq: KLTO) signed an LOI to acquire Turn Biotechnologies’ ERA platform and eTurna RNA system. The deal would expand its longevity therapeutics portfolio.
Read More
September 30, 2025
China’s Pharma Industry Targets First-in-Class Drug Innovation
Chinese pharma is moving from imitation to creating “first-in-class” drugs, aiming for original treatments with greater global impact and advancing its healthcare ambitions.
Read More
September 29, 2025
China Eliminates Import Tax on Indian Pharma
China has cut its 30% import duty on Indian medicines to zero, boosting India’s pharmaceutical exports and expanding global access to affordable drugs.
Read More
September 26, 2025
Trump Announces Pharma Tariffs to Boost U.S. Manufacturing
President Trump announced a 100% tariff on branded and patented drug imports starting October 1, 2025, to boost U.S. manufacturing, while generics are exempt. Companies must begin U.S. facility construction to avoid the tariff.
Read More
September 25, 2025
Trump’s H-1B Visa Fee Hike Sparks Fears of Worsening US Doctor Shortage
The Trump administration’s plan to raise H-1B visa fees up to $100,000 is alarming U.S. healthcare groups, who fear it will worsen the nation’s physician shortage.
Read More
September 24, 2025
Torrent Pharma Gets Approval to Acquire Controlling Stake in JB Chemicals
Torrent Pharmaceuticals has received regulatory approval from South Africa’s Competition Commission to proceed with its acquisition of JB Chemicals & Pharmaceuticals, advancing its strategic expansion.
Read More
September 23, 2025
Corning and SGD Pharma Inaugurate $60 Million Glass Tubing Facility in Hyderabad
US-based Corning and France’s SGD Pharma inaugurated their $60 million joint venture glass tubing plant for pharma products near Hyderabad.
Read More
September 19, 2025
India Expands Pharma Global Capability Centres, Driving Innovation and Jobs
India is becoming a key pharma hub, with 55+ global centres driving innovation and R&D, amid a $236B patent cliff affecting 70 blockbuster drugs by 2030.
Read More
September 18, 2025
Roche to Acquire 89bio in $3.5 Billion Deal, Expanding MASH Pipeline
Roche will acquire 89bio for $14.50 per share in cash, valuing it at $2.4B, with potential CVRs adding up to $3.5B; the deal is expected to close in Q4 2025.
Read More
September 17, 2025
GSK Unveils $30 Billion U.S. Investment Amid Pharma Tariff Threat
GSK (GSK.L) will invest $30B in U.S. R&D and supply chain over five years, aligning with Trump’s push for domestic drug manufacturing amid tariff threats.
Read More
September 16, 2025
aTyr Pharma Shares Plunge After Lung Disease Drug Fails in Late-Stage Trial
aTyr Pharma shares plunged over 80% after its experimental drug efzofitimod failed a late-stage trial for pulmonary sarcoidosis, a chronic lung disease.
Read More
September 15, 2025
Akeso Launches Global Phase II Trial of Cadonilimab in Advanced Liver Cancer
Akeso, Inc. began dosing the first patient in its global Phase II trial testing cadonilimab, a PD-1/CTLA-4 bispecific antibody, combined with lenvatinib versus lenvatinib alone in advanced hepatocellular carcinoma.
Read More
September 12, 2025
Britain Defends Investment Record as Merck Cancels London Research Centre
The UK government defended its investment record after Merck scrapped its £1 billion London research centre, despite construction already underway and a 2027 opening planned.
Read More
September 11, 2025
British Pharma Industry Warns Drug Pricing Policy is Driving Away Foreign Investment
The ABPI warns that Britain’s strict drug pricing policies are deterring foreign investment, with the UK dropping from 2nd place in 2017 to 7th in 2023 for pharma FDI.
Read More
September 10, 2025
Quotient Sciences and CPI Launch Joint Venture to Accelerate RNA Drug Development
Quotient Sciences and CPI have partnered to speed up mRNA drug development by combining Quotient’s Translational Pharmaceutics platform with CPI’s RNA synthesis and LNP expertise.
Read More
September 9, 2025
Novartis to Acquire Tourmaline Bio, Expanding Cardiovascular Pipeline
Novartis will acquire Tourmaline Bio for $1.4B to advance pacibekitug, a clinical-stage anti-IL-6 antibody targeting inflammation in atherosclerotic cardiovascular disease.
Read More
September 8, 2025
PacBio Adds EpiCypher to Compatible Program, Expands Chromatin Research Tools
PacBio has partnered with EpiCypher, enabling the use of CUTANA Hia5 enzyme in Fiber-seq assays on HiFi systems, advancing single-molecule chromatin and epigenetic research.
Read More
September 5, 2025
US Plans to Provide Gilead HIV Drug at Cost in High-Burden Countries
The U.S. will provide Gilead’s long-acting HIV drug lenacapavir “at cost” through PEPFAR and the Global Fund, aiming to reach 2 million people in high-burden countries within three years.
Read More
September 4, 2025
India Removes GST on Life and Health Insurance Premiums from September 22
The GST Council has exempted life and health insurance premiums from the 18% tax starting September 22, bringing major relief to policyholders who will now pay only the base premium.
Read More
September 3, 2025
Polpharma Biologics Partners with MS Pharma to Boost Biosimilar Access in MENA
Polpharma Biologics signs licensing deals with MS Pharma to bring three biosimilars to the MENA region. MS Pharma will oversee commercialization, and Polpharma will handle production and supply.
Read More
July 5, 2025
Supporting EU Pharma Success: A GTM Milestone
Through data-led insights, we helped a pharmaceutical client execute a successful drug launch in Europe.
Read More
June 10, 2025
MedTech Expansion in APAC: Insights That Matter
In-depth competitive analysis enabled our client to identify underserved hospital segments and expand strategically.
Read More
May 28, 2025
AI HealthTech Startups Gain Ground with Consumer Insight
AI-driven HealthTech startups are transforming the healthcare space by using consumer insight to develop personalized, predictive, and scalable digital health solutions.
Read More
May 8, 2025
Global Public Health Research Impacting Policy Frameworks
Groundbreaking global public health research is shaping national and international policy frameworks, leading to more informed, data-driven decisions for population health.
Read More